Dr Michael Kale is a medical doctor, working towards further specialist qualifications in surgery. In addition to his clinical experience, he has management and leadership experience in both the non-medical business and not-for-profit sectors.
Dr Kale is the company director of a Canadian biopharmaceutical company which is intending to list on the CSE in 2022, and a member of the Australian Institute of Company Directors.